![](/accounts/sepsisalliance/images/logo.png)
Sepsis Alliance Summit 2024
Description
*Over 350,000 U.S. adults killed each year.*
*The leading cause of death in U.S. hospitals.*
*Over 49 million people worldwide affected each year.*
This is sepsis.
Join us this September to learn more about how you can help better identify, diagnose, and treat this deadly condition in your practice. Mortality increases 4-9% for every hour that treatment is delayed. YOU can help save lives and limbs by staying up-to-date on current recommendations and guidelines around sepsis by joining us at the 5th Annual Sepsis Alliance Summit.
For the first time, Sepsis Alliance Summit is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.
Are you ready to learn with us? Register today for this free, virtual conference. You’ll earn RN CE credits and improve your practice, benefiting sepsis patients.
FREE Nursing CE Credits Offered!
Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing for 9.7 contact hours, Provider Number CEP17068.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
![image](https://c0ea946ea14de934f725-1840b682e23387c2aca618bb13b142d8.ssl.cf2.rackcdn.com/sepsisalliance_67497cc564616946d091ae33f0261dd0.png)
Agenda
September 25, 2024
Time (ET) | Session Title | Presenter |
---|---|---|
10:00-10:15 | Opening Remarks & The 2024 Erin Kay Flatley Spirit Award Winners | Carl Flatley, DDS, MSD Founder, Sepsis Alliance Jackie Duda Health and Travel Journalist Sepsis and Disability Advocate Julia Fraser Sepsis Survivor, Mrs. Texas |
10:20-10:30 | Day 1 Keynote: Advocacy and Awareness: Our Family's Journey with Sepsis and the Power of ‘Using Your Voice’ | Jake Tapper Anchor and Chief Washington Correspondent, CNN Alice Tapper Student & Patient Advocate Jennifer Tapper Sepsis Alliance – Board of Directors |
10:35-11:00 | Recognizing the Overlooked: Identifying Features of Delayed Sepsis Diagnoses (CE Session) | Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE Director, Safe Medical Care Research Canadian Medical Protective Association Eileen Bridges, MD, CCFP, MSc, Dip Sport Med. Senior Physician Advisor, Safe Medical Care Learning Canadian Medical Protective Association |
11:00-11:30 | A Sepsis Documentation Journey: Memorial Hospital of Union County (Ohio) (CE Session) | Amy Stephens, MBA, RN, CPHQ, CHC Assistant Vice President of Quality and Compliance, Memorial Hospital Robin Regula, RN Clinical Quality Specialist Memorial Hospital |
11:30-12:00 | Track 1: Recce Pharmaceuticals Sponsored Session: New Frontiers in Sepsis and Urosepsis Treatment: Synthetic Anti-Infectives to Combat Superbugs Track 2: Abionic Sponsored Session: Rapid Sepsis Screening - Can Pancreatic Stone Protein (PSP) Enhance ED Triage? | Track 1: James Graham Managing Director & Chief Executive Officer, Recce Pharmaceuticals Track 2: Andrew Shorr, MD Section Director, Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center (MWHC) Evangelos J. Giamarellos-Bourboulis, MD, PhD Professor of Internal Medicine and Infectious Diseases, Medical School of the National and Kapodistrian University of Athens Patrick Pestalozzi, MBA Chief Executive Officer, Abionic |
12:00-12:15 | Break | |
12:15-12:45 | Racial and Ethnic Disparities in Sepsis (CE Session) | Christopher F. Chesley, MD, MSCE Assistant Professor of Medicine Perelman School of Medicine at the University of Pennsylvania |
12:50-1:20 | Post-Intensive Care Syndrome in Survivors of Sepsis (CE Session) | Tracye Proffitt, PhD, RN, CNE Assistant Professor Virginia Commonwealth University School of Nursing |
1:25-1:55 | bioMérieux Sponsored Session: Comprehensive Clinical Solution Throughout the Acute Care Patient Journey | Daniel Feinstein, MD, MS, FACP, ACRP-PI Director of Pulmonary Critical Care Medicine, Novant Healthcare |
1:55-2:10 | Break | |
2:10-2:40 | Neonatal Sepsis: A Global Challenge (CE Session) | Pascal Lavoie, MDCM, PhD Professor of Pediatrics University of British Columbia |
2:45-3:30 | Sepsis: Threat to Cardiovascular Health (CE Session) | Mitchell S. V. Elkind, MD, MS FAHA Chief Clinical Science Officer American Heart Association |
3:35-3:50 | Track 1: Roche Sponsored Session: Immunotherapy of Sepsis Guided by Biomarkers Track 2: Flosonics Medical Sponsored Session: Cracking SEP-1: Your Guide to Acing Fluid Administration Requirements | Track 1: Richard S. Hotchkiss, MD
Professor of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine Track 2: Jaclyn Bond, MSN-LM, MBA-HM, RN Director of Nursing, Riverside University Health System |
3:55-4:10 | Track 1: InflaRx Sponsored Session: For Some Patients, COVID-19 Remains a Serious Threat Track 2: SeaStar Medical Sponsored Session: Pediatric Sepsis, The Unique Fallout of a Global Killer | Track 1: Bruce P. Burnett, PhD VP, Head of Medical Affairs, InflaRx Track 2: Rajit K. Basu, MD, MS, FCCM Division Chief of Critical Care Medicine Ann & Robert Lurie Children’s Hospital of Chicago |
4:15-4:45 | Advancing Health Equity for Sepsis Patients with Limited English Proficiency: Reducing Length of Stay and Readmissions (CE Session) | Moojan Rezvan, MBA Supervisor, Interpreter Services & Diversity Services, Providence Mission Hospital Emily Cusick, BSN, RN, CCRN Sepsis Clinical Coordinator Providence Mission Hospital |
4:50-5:00 | Day 1 Closing Remarks | Hannah Sass
Sepsis Alliance |
September 26, 2024
September 27, 2024
For the first time, Sepsis Alliance is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.
Time (ET) | Session Title | Presenter |
---|---|---|
10:00-10:10 | Opening Remarks and Land Acknowledgement | David Carlbom, MD
Associate Professor of Medicine, Pulmonary Critical Care and Sleep Medicine University of Washington School of Medicine Medical Director, Respiratory Care Department Attending Physician, Medical and Trauma-Surgical Intensive Care Units Harborview Medical Center Katy Grainger Sepsis Survivor and Advocate |
10:10-10:55 | Session 1: Implementation of Pediatric Sepsis Phoenix Criteria Across the Globe: Building Equity? | Moderator: Scott P. Sherry, MS, PA-C, FCCM Sepsis Program Manager, Oregon Health and Science University Doernbecher Children’s Hospital Nelson Sanchez-Pinto, MD, MBI, FAMIA Northwestern University - Feinberg School of Medicine Andrew Argent, MBBCh, MMed, MD, FRCPCH (UK) |
11:00-11:55 | Session 2: Challenges & Opportunities for Improving Maternal Sepsis Care | Moderator: Scott P. Sherry, MS, PA-C, FCCM
Sepsis Program Manager, Oregon Health and Science University Doernbecher Children’s Hospital Cathryn Ellis. BFA, MSc. PhD, RM (non-practicing) Associate Professor Emeritus University of British Columbia Elliott K. Main, MD Professor of Obstetrics and Gynecology Stanford University School of Medicine María Fernanda Escobar Vidarte, MD Chief of the Global Health Equity Unit Universidad del Valle, Cali - Colombia |
12:00-12:30 | Break | |
12:30-1:30 | Session 3: Bedside Education - Teaching Providers How to Apply Best Practices | Moderator: Rick Janik, BSN, RN, CEN, CFRN
Flight Nurse, Airlift Northwest Laura Evans, MD, MSc Professor and Medical Director Critical Care, University of Washington Halima Salisu-Kabara, FWACN, MPA, RN-RM, CCRN Vice-Executive Director African Sepsis Alliance (ASA) |
1:30-2:25 | Session 4: Bench to Bedside: Updates in Sepsis Science | Moderator: Mary Jo Kelly DNP, ARNP-CNS, CCNS, CCRN Elizabeth Bridges PhD, RN, CCNS, FCCM, FAAN University of Washington Medical Center |
2:30-3:25 | Session 5: Sepsis Survivorship | Moderator: Sybil Hoiss, RN, MN
Lead, Clinical Initiatives & Innovation Critical Care BC, Provincial Health Services Authority Hailey Bain Sepsis Survivor and Patient Partner Sepsis Canada Mark E. Mikkelsen, MD, MSCE, FCCM Associate Chief Medical Officer, Critical Care University of Colorado Hospital Stephanie Taylor, MD, MS Division Chief of Hospital Medicine University of Michigan |
3:30-4:00 | Closing Remarks: Pulling It All Together | Fatima Sheikh, MSc Communications Assistant Sepsis Canada Katy Grainger Sepsis Survivor and Advocate |
Advanced Search This List
-
Includes a Live Web Event on 09/25/2024 at 7:00 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 10:00 - 10:15 am ET
During these opening remarks, Sepsis Alliance will introduce this year’s 2024 Erin Kay Flatley Spirit Award Winner. Attendees will hear from the two awardees, as they share their sepsis stories and advocacy work they both do to help prevent, educate, and drive awareness of the deadly impact of sepsis.
The Erin Kay Flatley Spirit Award recognizes outstanding dedication, sacrifice, and contribution to improving sepsis awareness and reducing the suffering caused by sepsis. Dr. Carl Flatley, the founder of Sepsis Alliance and Erin’s dad, will once more introduce this year’s awardees and present them with the award.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Carl Flatley, DDS, MSD
Founder
Sepsis Alliance
On April 30, 2002, Carl Flatley’s life changed. It was the day his daughter, Erin, died from septic shock, something Carl Flatley, DDS, MSD, a retired endodontist, had never heard of. After Erin’s death, Dr. Flatley learned everything he could about sepsis, and was astounded by what he – and millions of other Americans – didn’t know about the condition. He was shocked to learn that, at the time, sepsis killed well over 200,000 people in the U.S. every year and even survivors were often left with serious after-effects. In 2004, Dr. Flatley founded the American Sepsis Alliance, which became Sepsis Alliance in 2007. It became his mission to make sepsis as well-known as cancer, diabetes, and other illnesses. His catchphrase became “So More Survive,” encapsulating his commitment to seeing fewer lives and limbs lost to sepsis. This unending devotion to Erin’s memory has had a significant impact on many people.
$i++ ?>
Jackie Duda
Health and Travel Journalist , Sepsis and Disability Advocate
Jackie taught English with Montgomery County Public Schools for 9 years, and then dove into freelance writing in 2001. She wrote extensively for publications including The Washington Post, Woman's Day, Costco Connection, and other major outlets. Her writing career came to a screeching halt in 2012 when Crohn's Disease, Postural Orthostatic Tachycardia Syndrome (P.O.T.S.), and Hypermobile Ehlers-Danlos hEDS, got the best of her and she became fully disabled. Osteoporosis eventually got a grip as well. A colon perforation and septic shock almost took her life on May 22, 2021, and she was flown to Baltimore for emergency surgery that saved her life. She’s made dramatic improvements during her lengthy and ongoing recovery. She continues to grapple with disabilities but is feeling better than she has in years. She contacted a few former editors, and they welcomed her pitches. Her first national comeback article appeared in Costco Connection and more soon followed in The Washington Post, Reader’s Digest, and AARP. She is making the most of her second chance at life and getting back into serious journalism. What she had thought was her ending, was really another beginning.
$i++ ?>
Julia Fraser
Sepsis Survivor, Mrs. Texas
Julia Fraser is a dynamic leader and advocate, currently serving as Mrs. Texas American 2024. A survivor of sepsis, Julia has channeled her experience into a powerful platform, championing sepsis awareness and prevention, while also passing city and state-wide proclamations. As an entrepreneur in the tech startup industry, she combines her passion for innovation with a dedication to making a difference in her community. Julia is also a loving wife to professional hockey player Cole Fraser, and together, they share their lives with their 2 dogs. Her journey reflects resilience, ambition, and a commitment to positively impacting those around her.
$i++ ?>
-
Includes a Live Web Event on 09/25/2024 at 7:20 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 10:20 - 10:30 am ET
During this impactful keynote session, Jake Tapper and his daughter Alice Tapper will share their family’s personal and deeply moving story of how a preventable missed diagnosis of appendicitis led to Alice developing sepsis. They will discuss their family's mission to raise awareness about sepsis, emphasize the importance of listening to patients and their families, and highlight Alice's advocacy work, including her new book, "Use Your Voice." Attendees will gain insights into the critical role healthcare professionals play in preventing sepsis and the power of patient and family advocacy.
Learning Objectives:
At the end of this session, the learner should be able to:
- Describe the potential consequences of delayed or missed diagnoses and their impact on patient outcomes;
- Recognize the importance of patient and family advocacy in healthcare and how to incorporate their perspectives into clinical decision-making.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jake Tapper
Anchor and Chief Washington Correspondent
CNN
CNN anchor and chief Washington correspondent Jake Tapper joined the network in January 2013. Tapper currently anchors an award-winning two-hour weekday program, The Lead with Jake Tapper, which debuted in March 2013. He has hosted CNN’s Sunday morning show, State of the Union, since June 2015. In April 2021, he became the lead anchor for CNN for Washington, D.C. events.
In addition to his reporting, Tapper has also authored five books, including his debut novel The Hellfire Club, published in 2018, its sequel, The Devil May Dance, published in 2021, both of which were New York Times best-sellers. His non-fiction works include the best-seller The Outpost: An Untold Story of American Valor, published in 2012, Down and Dirty: The Plot to Steal the Presidency, which was published in 2001, and Body Slam: The Jesse Ventura Story, which was published in 1999. The Outpost debuted in the top 10 on The New York Times best seller list, and Tapper was one of the executive producers of the critically acclaimed film version of The Outpost, directed by Rod Lurie and released in 2020. His next highly anticipated novel, All The Demons Are Here, was published in July 2023.
In addition to raising sepsis awareness, Tapper has been active in bringing attention and support for veterans’ issues. Since 2017 he has organized an annual celebrity eBay auction to build specially-designed mortgage-free houses for severely injured veterans of the wars of Iraq and Afghanistan via the top-rated charity Homes for Our Troops, a group for which he serves as an ambassador. In 2018, he was awarded a People’s Choice Vetty during the 3rd Annual Vetty Awards, an annual award ceremony presented by the Academy of United States Veterans. In 2014, Tapper’s book and his reporting on the veterans and troops were cited when the Congressional Medal of Honor Society awarded him the “Tex” McCrary Award for Excellence in Journalism. He graduated Phi Beta Kappa, Magna Cum Laude from Dartmouth College in 1991 and lives in Washington, D.C., with his wife, daughter and son.
$i++ ?>
Alice Tapper
Student & Patient Advocate
$i++ ?>
Jennifer Tapper
Sepsis Alliance – Board of Directors
Jennifer Tapper is an advocacy-based fundraising, organizing, and communications professional with more than 20 years of experience fighting for equality, equity, and basic human rights for women and children. In 2021, Jennifer’s daughter, Alice, was admitted to the hospital with appendicitis, but doctors missed the warning signs and Alice was initially misdiagnosed. By the time she was correctly diagnosed, her appendix had ruptured, and she became septic. You can read Alice’s full story here. Alice was ultimately able to make a full recovery and has become a national advocate for diagnostic change when it comes to appendicitis and sepsis. Jennifer and Alice are committed to modernizing the way emergency room doctors diagnose appendicitis. They both speak to medical students and health care providers to share Alice’s story and inform others of the dangers of not recognizing the signs of appendicitis, pre-sepsis, and sepsis. Jennifer lives in Washington, D.C. with her husband, Jake Tapper, and her two children, Jack and Alice Tapper.
$i++ ?>
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Use this Community as a place to connect, ask questions of your peers, and share your organization's AMR, Infection Prevention, HAI, and sepsis journeys and tools.
-
Complete this to download your CE Certificate for Sepsis Alliance AMR Conference 2024
Complete this evaluation to download your CE Certificate for Sepsis Alliance Summit 2024.
-
Includes a Live Web Event on 09/25/2024 at 7:35 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 10:35 - 11:00 am ET
In this session, the presenters will explore the critical indicators of delayed or missed sepsis diagnoses using insights derived from a repository of Canadian medico-legal cases. Presented by Dr. Eileen Bridges, an emergency medicine specialist, and Dr. Gary Garber, an infectious disease specialist, attendees will identify features of delayed or missed diagnosis of sepsis and understand risks associated with undifferentiated patients. The session will also emphasize the importance of discharge instructions and communication with the patient and their family to improve patient safety.
Learning Objectives:
At the end of this session, the learner should be able to:
- Identify features of patients with delayed or missed diagnosis of infections;
- Summarize the importance of discharge instructions and communication with the patient to improve patient safety;
- Describe the risks associated with uncertainty in the undifferentiated patient.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE
Director, Safe Medical Care Research
Canadian Medical Protective Association
Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE, is an infectious diseases physician based at The Ottawa Hospital where he focuses on infections in the immunocompromised host, HIV, and viral hepatitis. He currently is a Professor in the Department of Medicine at the University of Ottawa and the University of Toronto. Dr. Garber was previously the Chief of the Infectious Disease Prevention and Control Department at Public Health Ontario where he provided medical and scientific leadership on infection control and antimicrobial stewardship. He received his BSc from McGill University, and his medical degree from the University of Calgary. He trained in Internal Medicine at the University of Toronto and Infectious Diseases at the University of British Columbia. His research has been in appropriate use of antibiotics and novel compounds, sepsis, pathogenesis of Trichomonas vaginalis and infection prevention, and control interventions to reduce nosocomial infections and improve patient safety.
$i++ ?>
Eileen Bridges, MD, CCFP, MSc, Dip Sport Med.
Senior Physician Advisor, Safe Medical Care Learning
Canadian Medical Protective Association
Eileen Bridges, MD, CCFP, MSc, Dip Sport Med., completed her medical degree at the University of Ottawa. She gained her certification in family medicine and earned a fellowship in sports medicine and a Masters in Exercise Physiology at McGill University. Dr. Bridges practiced emergency and sports medicine at McGill University where she was an assistant professor and has served in many capacities in medical education at the undergraduate and postgraduate level. Nationally, she has served with the Canadian Association of Emergency Physicians (CAEP), the Canadian Academy of Sport and Exercise Medicine (CASEM), and the Medical Council of Canada.
$i++ ?>
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 09/25/2024 at 8:00 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 11:00 - 11:30 am ET
This presentation will give an overview of the Sepsis Core Measure compliance journey of a 99-bed independent hospital in Marysville, Ohio. Attendees will gain a clear understanding of the Sepsis Core Measure requirements, why they are crucial for patient outcomes, and how they impact hospital performance metrics. They will also learn about specific strategies and best practices implemented to enhance physician documentation related to sepsis. This session will include practical tips, tools used, and training methods that contributed to better compliance with the Sepsis Core Measure. Lastly, learners will also explore the lessons learned from the hospital’s journey, including challenges faced and how they were overcome. This will cover both successful tactics and areas for improvement, providing a comprehensive view of the impact on sepsis management and patient care quality.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review the Sepsis Core Measure requirements and their importance;
- Identify key strategies for improving physician documentation;
- Analyze and compare the lessons learned and outcomes achieved to their own organizational sepsis protocols and documentation initiatives.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Amy Stephens, MBA, RN, CPHQ, CHC
Assistant Vice President of Quality and Compliance
Memorial Hospital
Amy Stephens is the Assistant Vice President of Quality and Compliance and Chief Compliance Officer at Memorial Hospital of Union County in Marysville, Ohio. With over a decade of service at Memorial Hospital, Amy has been instrumental in elevating clinical quality and care standards. Her commitment to ensuring regulatory and accreditation excellence is evident through her oversight of diverse teams within Case Management, Quality, and Infection Control. Amy's clinical background and previous experience as a surveyor with the Ohio Department of Health provided her with a robust foundation for her current regulatory oversight responsibilities and a passion for patient safety and process improvement. Holding an MBA in Healthcare Management, Associate of Science/Registered Nurse (RN), certifications as a Certified Professional in Healthcare Quality (CPHQ), Certified in Healthcare Compliance (CHC), a Lean Six Sigma Black Belt for Healthcare, and as an ISO 9001 Lead Auditor, Amy’s leadership and expertise continue to drive Memorial Hospital toward achieving and sustaining the highest standards of healthcare excellence.
$i++ ?>
Robin Regula, RN
Clinical Quality Specialist
Memorial Hospital
Robin Regula, RN, is the Clinical Quality Specialist at Memorial Hospital of Union County in Marysville, Ohio. She is the hospital’s de facto Sepsis Coordinator and has been abstracting for the Sepsis Core Measure since its implementation in 2015. Robin's extensive background in clinical nursing, emergency nursing, occupational health, and quality uniquely positions her to drive quality and process improvement initiatives at the hospital. Her dedication to enhancing patient care and outcomes led her to join the Quality team in 2015, where she continues to make a significant impact.
$i++ ?>
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 09/25/2024 at 8:30 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 11:30 am - 12:00 pm ET
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens. With no new class of antibiotics in over 30 years, a novel class of medication that can tackle multidrug-resistant bacteria and does not increase antibiotic resistance is essential to tackle the constant infective threat. In this sponsored session, learn about Recce’s synthetic anti-infective compound, RECCE® 327 (R327), which has demonstrated bactericidal activity against all ESKAPEE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli) without contributing to resistance. With a unique mechanism of action, the compound has the ability to continuously kill multidrug-resistant superbugs. Discover how Recce Pharmaceuticals Ltd is revolutionizing the fight against sepsis, urosepsis, and more with their innovative class of synthetic anti-infectives. With successful outcomes in Phase I/II trials and preparations for Phase III in Indonesia, Recce's RECCE® 327 shows significant promise against antibiotic-resistant superbugs.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
James Graham
Managing Director & Chief Executive Officer
Recce Pharmaceuticals
James Graham is the Chief Executive Officer of Recce Pharmaceuticals. He was formerly Executive Director and has extensive experience in marketing, business development, and commercialization of early-stage technologies with global potential. Mr. Graham serves on Recce’s Board of Directors and has invested in almost every capital raise to date with a focus on expanding Recce’s commercial opportunities and clinical initiatives.
$i++ ?>
-
Includes a Live Web Event on 09/25/2024 at 8:30 AM (PDT)
Abionic Sponsored Session, Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 11:30 am - 12:00 pm ET
This sponsored session will cover existing sepsis assessment tools and their shortcomings and will introduce Pancreatic Stone Protein (PSP) as an emerging sepsis biomarker. The presenters will describe how PSP can be used as a complement to existing tools to enhance the ability of ED staff to screen incoming patients for Community Acquired Sepsis (CAS) and improve current "Rule-In" scores to ensure optimal patient outcome. Learners will also hear a real-world example of a use case for PSP which saved a young patient with sepsis in a Greek hospital.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Andrew Shorr, MD
Section Director, Pulmonary and Critical Care Medicine
Medstar Washington Hospital Center (MWHC)
Andrew Shorr, MD, is a distinguished American physician and professor, recognized for his significant contributions in the field of pulmonary and critical care medicine. He has been actively involved in clinical research, focusing on respiratory infections, sepsis, and antibiotic resistance. Dr. Shorr has authored numerous peer-reviewed articles and has been a prominent figure in advancing understanding and treatment of critical illnesses in the intensive care unit. Additionally, he has held leadership roles in various medical institutions and professional organizations, enhancing both clinical practice and medical education.
$i++ ?>
Evangelos J. Giamarellos-Bourboulis, MD, PhD
Professor of Internal Medicine and Infectious Diseases
Medical School of the National and Kapodistrian University of Athens
Evangelos Giamarellos-Bourboulis, MD, PhD, is a Professor of Internal Medicine and Infectious Diseases at the Medical School of the National and Kapodistrian University of Athens. He was trained in the immunology of infections at the Department of Internal Medicine and Infectious Disease of Radboud University in the Netherlands. In 2012 and 2013, he served as Guest Professor of the Department of Critical Care Medicine of Jena University Hospital in Germany. Dr. Giamarellos-Bourboulis’ research focuses on immunomodulation in sepsis and in auto-inflammatory disorders for which he was awarded the Young Investigator Research Award by the European Society of Clinical Microbiology and Infectious Diseases. He has 538 publications in international peer-reviewed journals with more than 35,000 citations. He has contributed in the development of clarithromycin for immunomodulatory treatment of septic shock, the recognition of hidradenitis suppurativa (HS) as an auto-inflammatory disorder, and in the licensing of adalimumab for treatment of (HS). He is the current chairman of the European Sepsis Alliance. His main achievement is the approval of anakinra for COVID-19 pneumonia in adults by the European Medicines Agency and the Food and Drug Administration through the phase 2 and 3 trials SAVE and SAVE-MORE that he designed and conducted.
$i++ ?>
Patrick Pestalozzi, MBA
Chief Executive Officer
Abionic
Patrick Pestalozzi is a former management consultant and Silicon Valley executive who is actively involved in the creation, financing, and development of multiple deep-tech startups. As a mentor, adviser, and coach to early-stage and mature organizations, he helps founders in the areas of growth strategies, product management, organizational design, international development, and sales performance. As a dual Swiss/US citizen who speaks English, French, and German, he maintains global insight and cultural sensitivity from extensive travel/work in 60+ countries.
$i++ ?>
-
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 12:00 - 12:15 pm ET
-
Includes a Live Web Event on 09/25/2024 at 9:15 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 12:15 - 12:45 pm ET
This session delves into the critical issue of racial and ethnic disparities in sepsis care and outcomes. Attendees will gain insights into sepsis-related definitions of equity and racism and examine the extent of these disparities within healthcare systems. The presentation will also explore various proposed mechanisms contributing to these disparities, assessing their validity and impact. How systemic factors influence sepsis outcomes among different racial and ethnic groups and the importance of addressing these inequities in clinical practice will also be highlighted.
Learning Objectives
At the end of this session, the learner should be able to:
- Restate sepsis-relevant definitions of equity and racism;
- Describe known racial and ethnic disparities relevant to sepsis care and outcomes;
- Evaluate the strength of proposed mechanisms for sepsis disparities.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Christopher F. Chesley, MD, MSCE
Assistant Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Christopher F. Chesley, MD, MSCE. is an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is an adult pulmonologist, intensivist, and health equity researcher whose research work evaluates structural mechanisms for critical care disparities and develops health system initiatives to mitigate them.
$i++ ?>
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 09/25/2024 at 7:00 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 10:00 - 10:15 am ET
During these opening remarks, Sepsis Alliance will introduce this year’s 2024 Erin Kay Flatley Spirit Award Winner. Attendees will hear from the two awardees, as they share their sepsis stories and advocacy work they both do to help prevent, educate, and drive awareness of the deadly impact of sepsis.
The Erin Kay Flatley Spirit Award recognizes outstanding dedication, sacrifice, and contribution to improving sepsis awareness and reducing the suffering caused by sepsis. Dr. Carl Flatley, the founder of Sepsis Alliance and Erin’s dad, will once more introduce this year’s awardees and present them with the award.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Carl Flatley, DDS, MSD
Founder
Sepsis Alliance
On April 30, 2002, Carl Flatley’s life changed. It was the day his daughter, Erin, died from septic shock, something Carl Flatley, DDS, MSD, a retired endodontist, had never heard of. After Erin’s death, Dr. Flatley learned everything he could about sepsis, and was astounded by what he – and millions of other Americans – didn’t know about the condition. He was shocked to learn that, at the time, sepsis killed well over 200,000 people in the U.S. every year and even survivors were often left with serious after-effects. In 2004, Dr. Flatley founded the American Sepsis Alliance, which became Sepsis Alliance in 2007. It became his mission to make sepsis as well-known as cancer, diabetes, and other illnesses. His catchphrase became “So More Survive,” encapsulating his commitment to seeing fewer lives and limbs lost to sepsis. This unending devotion to Erin’s memory has had a significant impact on many people.
Jackie Duda
Health and Travel Journalist , Sepsis and Disability Advocate
Jackie taught English with Montgomery County Public Schools for 9 years, and then dove into freelance writing in 2001. She wrote extensively for publications including The Washington Post, Woman's Day, Costco Connection, and other major outlets. Her writing career came to a screeching halt in 2012 when Crohn's Disease, Postural Orthostatic Tachycardia Syndrome (P.O.T.S.), and Hypermobile Ehlers-Danlos hEDS, got the best of her and she became fully disabled. Osteoporosis eventually got a grip as well. A colon perforation and septic shock almost took her life on May 22, 2021, and she was flown to Baltimore for emergency surgery that saved her life. She’s made dramatic improvements during her lengthy and ongoing recovery. She continues to grapple with disabilities but is feeling better than she has in years. She contacted a few former editors, and they welcomed her pitches. Her first national comeback article appeared in Costco Connection and more soon followed in The Washington Post, Reader’s Digest, and AARP. She is making the most of her second chance at life and getting back into serious journalism. What she had thought was her ending, was really another beginning.
Julia Fraser
Sepsis Survivor, Mrs. Texas
Julia Fraser is a dynamic leader and advocate, currently serving as Mrs. Texas American 2024. A survivor of sepsis, Julia has channeled her experience into a powerful platform, championing sepsis awareness and prevention, while also passing city and state-wide proclamations. As an entrepreneur in the tech startup industry, she combines her passion for innovation with a dedication to making a difference in her community. Julia is also a loving wife to professional hockey player Cole Fraser, and together, they share their lives with their 2 dogs. Her journey reflects resilience, ambition, and a commitment to positively impacting those around her.
-
Includes a Live Web Event on 09/25/2024 at 7:20 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 10:20 - 10:30 am ET
During this impactful keynote session, Jake Tapper and his daughter Alice Tapper will share their family’s personal and deeply moving story of how a preventable missed diagnosis of appendicitis led to Alice developing sepsis. They will discuss their family's mission to raise awareness about sepsis, emphasize the importance of listening to patients and their families, and highlight Alice's advocacy work, including her new book, "Use Your Voice." Attendees will gain insights into the critical role healthcare professionals play in preventing sepsis and the power of patient and family advocacy.
Learning Objectives:
At the end of this session, the learner should be able to:
- Describe the potential consequences of delayed or missed diagnoses and their impact on patient outcomes;
- Recognize the importance of patient and family advocacy in healthcare and how to incorporate their perspectives into clinical decision-making.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jake Tapper
Anchor and Chief Washington Correspondent
CNN
CNN anchor and chief Washington correspondent Jake Tapper joined the network in January 2013. Tapper currently anchors an award-winning two-hour weekday program, The Lead with Jake Tapper, which debuted in March 2013. He has hosted CNN’s Sunday morning show, State of the Union, since June 2015. In April 2021, he became the lead anchor for CNN for Washington, D.C. events.
In addition to his reporting, Tapper has also authored five books, including his debut novel The Hellfire Club, published in 2018, its sequel, The Devil May Dance, published in 2021, both of which were New York Times best-sellers. His non-fiction works include the best-seller The Outpost: An Untold Story of American Valor, published in 2012, Down and Dirty: The Plot to Steal the Presidency, which was published in 2001, and Body Slam: The Jesse Ventura Story, which was published in 1999. The Outpost debuted in the top 10 on The New York Times best seller list, and Tapper was one of the executive producers of the critically acclaimed film version of The Outpost, directed by Rod Lurie and released in 2020. His next highly anticipated novel, All The Demons Are Here, was published in July 2023.
In addition to raising sepsis awareness, Tapper has been active in bringing attention and support for veterans’ issues. Since 2017 he has organized an annual celebrity eBay auction to build specially-designed mortgage-free houses for severely injured veterans of the wars of Iraq and Afghanistan via the top-rated charity Homes for Our Troops, a group for which he serves as an ambassador. In 2018, he was awarded a People’s Choice Vetty during the 3rd Annual Vetty Awards, an annual award ceremony presented by the Academy of United States Veterans. In 2014, Tapper’s book and his reporting on the veterans and troops were cited when the Congressional Medal of Honor Society awarded him the “Tex” McCrary Award for Excellence in Journalism. He graduated Phi Beta Kappa, Magna Cum Laude from Dartmouth College in 1991 and lives in Washington, D.C., with his wife, daughter and son.
Alice Tapper
Student & Patient Advocate
Jennifer Tapper
Sepsis Alliance – Board of Directors
Jennifer Tapper is an advocacy-based fundraising, organizing, and communications professional with more than 20 years of experience fighting for equality, equity, and basic human rights for women and children. In 2021, Jennifer’s daughter, Alice, was admitted to the hospital with appendicitis, but doctors missed the warning signs and Alice was initially misdiagnosed. By the time she was correctly diagnosed, her appendix had ruptured, and she became septic. You can read Alice’s full story here. Alice was ultimately able to make a full recovery and has become a national advocate for diagnostic change when it comes to appendicitis and sepsis. Jennifer and Alice are committed to modernizing the way emergency room doctors diagnose appendicitis. They both speak to medical students and health care providers to share Alice’s story and inform others of the dangers of not recognizing the signs of appendicitis, pre-sepsis, and sepsis. Jennifer lives in Washington, D.C. with her husband, Jake Tapper, and her two children, Jack and Alice Tapper.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Use this Community as a place to connect, ask questions of your peers, and share your organization's AMR, Infection Prevention, HAI, and sepsis journeys and tools.
-
Complete this to download your CE Certificate for Sepsis Alliance AMR Conference 2024
Complete this evaluation to download your CE Certificate for Sepsis Alliance Summit 2024.
-
Includes a Live Web Event on 09/25/2024 at 7:35 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 10:35 - 11:00 am ET
In this session, the presenters will explore the critical indicators of delayed or missed sepsis diagnoses using insights derived from a repository of Canadian medico-legal cases. Presented by Dr. Eileen Bridges, an emergency medicine specialist, and Dr. Gary Garber, an infectious disease specialist, attendees will identify features of delayed or missed diagnosis of sepsis and understand risks associated with undifferentiated patients. The session will also emphasize the importance of discharge instructions and communication with the patient and their family to improve patient safety.
Learning Objectives:
At the end of this session, the learner should be able to:
- Identify features of patients with delayed or missed diagnosis of infections;
- Summarize the importance of discharge instructions and communication with the patient to improve patient safety;
- Describe the risks associated with uncertainty in the undifferentiated patient.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE
Director, Safe Medical Care Research
Canadian Medical Protective Association
Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE, is an infectious diseases physician based at The Ottawa Hospital where he focuses on infections in the immunocompromised host, HIV, and viral hepatitis. He currently is a Professor in the Department of Medicine at the University of Ottawa and the University of Toronto. Dr. Garber was previously the Chief of the Infectious Disease Prevention and Control Department at Public Health Ontario where he provided medical and scientific leadership on infection control and antimicrobial stewardship. He received his BSc from McGill University, and his medical degree from the University of Calgary. He trained in Internal Medicine at the University of Toronto and Infectious Diseases at the University of British Columbia. His research has been in appropriate use of antibiotics and novel compounds, sepsis, pathogenesis of Trichomonas vaginalis and infection prevention, and control interventions to reduce nosocomial infections and improve patient safety.
Eileen Bridges, MD, CCFP, MSc, Dip Sport Med.
Senior Physician Advisor, Safe Medical Care Learning
Canadian Medical Protective Association
Eileen Bridges, MD, CCFP, MSc, Dip Sport Med., completed her medical degree at the University of Ottawa. She gained her certification in family medicine and earned a fellowship in sports medicine and a Masters in Exercise Physiology at McGill University. Dr. Bridges practiced emergency and sports medicine at McGill University where she was an assistant professor and has served in many capacities in medical education at the undergraduate and postgraduate level. Nationally, she has served with the Canadian Association of Emergency Physicians (CAEP), the Canadian Academy of Sport and Exercise Medicine (CASEM), and the Medical Council of Canada.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 09/25/2024 at 8:00 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 11:00 - 11:30 am ET
This presentation will give an overview of the Sepsis Core Measure compliance journey of a 99-bed independent hospital in Marysville, Ohio. Attendees will gain a clear understanding of the Sepsis Core Measure requirements, why they are crucial for patient outcomes, and how they impact hospital performance metrics. They will also learn about specific strategies and best practices implemented to enhance physician documentation related to sepsis. This session will include practical tips, tools used, and training methods that contributed to better compliance with the Sepsis Core Measure. Lastly, learners will also explore the lessons learned from the hospital’s journey, including challenges faced and how they were overcome. This will cover both successful tactics and areas for improvement, providing a comprehensive view of the impact on sepsis management and patient care quality.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review the Sepsis Core Measure requirements and their importance;
- Identify key strategies for improving physician documentation;
- Analyze and compare the lessons learned and outcomes achieved to their own organizational sepsis protocols and documentation initiatives.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Amy Stephens, MBA, RN, CPHQ, CHC
Assistant Vice President of Quality and Compliance
Memorial Hospital
Amy Stephens is the Assistant Vice President of Quality and Compliance and Chief Compliance Officer at Memorial Hospital of Union County in Marysville, Ohio. With over a decade of service at Memorial Hospital, Amy has been instrumental in elevating clinical quality and care standards. Her commitment to ensuring regulatory and accreditation excellence is evident through her oversight of diverse teams within Case Management, Quality, and Infection Control. Amy's clinical background and previous experience as a surveyor with the Ohio Department of Health provided her with a robust foundation for her current regulatory oversight responsibilities and a passion for patient safety and process improvement. Holding an MBA in Healthcare Management, Associate of Science/Registered Nurse (RN), certifications as a Certified Professional in Healthcare Quality (CPHQ), Certified in Healthcare Compliance (CHC), a Lean Six Sigma Black Belt for Healthcare, and as an ISO 9001 Lead Auditor, Amy’s leadership and expertise continue to drive Memorial Hospital toward achieving and sustaining the highest standards of healthcare excellence.
Robin Regula, RN
Clinical Quality Specialist
Memorial Hospital
Robin Regula, RN, is the Clinical Quality Specialist at Memorial Hospital of Union County in Marysville, Ohio. She is the hospital’s de facto Sepsis Coordinator and has been abstracting for the Sepsis Core Measure since its implementation in 2015. Robin's extensive background in clinical nursing, emergency nursing, occupational health, and quality uniquely positions her to drive quality and process improvement initiatives at the hospital. Her dedication to enhancing patient care and outcomes led her to join the Quality team in 2015, where she continues to make a significant impact.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 09/25/2024 at 8:30 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 11:30 am - 12:00 pm ET
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens. With no new class of antibiotics in over 30 years, a novel class of medication that can tackle multidrug-resistant bacteria and does not increase antibiotic resistance is essential to tackle the constant infective threat. In this sponsored session, learn about Recce’s synthetic anti-infective compound, RECCE® 327 (R327), which has demonstrated bactericidal activity against all ESKAPEE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli) without contributing to resistance. With a unique mechanism of action, the compound has the ability to continuously kill multidrug-resistant superbugs. Discover how Recce Pharmaceuticals Ltd is revolutionizing the fight against sepsis, urosepsis, and more with their innovative class of synthetic anti-infectives. With successful outcomes in Phase I/II trials and preparations for Phase III in Indonesia, Recce's RECCE® 327 shows significant promise against antibiotic-resistant superbugs.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
James Graham
Managing Director & Chief Executive Officer
Recce Pharmaceuticals
James Graham is the Chief Executive Officer of Recce Pharmaceuticals. He was formerly Executive Director and has extensive experience in marketing, business development, and commercialization of early-stage technologies with global potential. Mr. Graham serves on Recce’s Board of Directors and has invested in almost every capital raise to date with a focus on expanding Recce’s commercial opportunities and clinical initiatives.
-
Includes a Live Web Event on 09/25/2024 at 8:30 AM (PDT)
Abionic Sponsored Session, Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 11:30 am - 12:00 pm ET
This sponsored session will cover existing sepsis assessment tools and their shortcomings and will introduce Pancreatic Stone Protein (PSP) as an emerging sepsis biomarker. The presenters will describe how PSP can be used as a complement to existing tools to enhance the ability of ED staff to screen incoming patients for Community Acquired Sepsis (CAS) and improve current "Rule-In" scores to ensure optimal patient outcome. Learners will also hear a real-world example of a use case for PSP which saved a young patient with sepsis in a Greek hospital.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Andrew Shorr, MD
Section Director, Pulmonary and Critical Care Medicine
Medstar Washington Hospital Center (MWHC)
Andrew Shorr, MD, is a distinguished American physician and professor, recognized for his significant contributions in the field of pulmonary and critical care medicine. He has been actively involved in clinical research, focusing on respiratory infections, sepsis, and antibiotic resistance. Dr. Shorr has authored numerous peer-reviewed articles and has been a prominent figure in advancing understanding and treatment of critical illnesses in the intensive care unit. Additionally, he has held leadership roles in various medical institutions and professional organizations, enhancing both clinical practice and medical education.
Evangelos J. Giamarellos-Bourboulis, MD, PhD
Professor of Internal Medicine and Infectious Diseases
Medical School of the National and Kapodistrian University of Athens
Evangelos Giamarellos-Bourboulis, MD, PhD, is a Professor of Internal Medicine and Infectious Diseases at the Medical School of the National and Kapodistrian University of Athens. He was trained in the immunology of infections at the Department of Internal Medicine and Infectious Disease of Radboud University in the Netherlands. In 2012 and 2013, he served as Guest Professor of the Department of Critical Care Medicine of Jena University Hospital in Germany. Dr. Giamarellos-Bourboulis’ research focuses on immunomodulation in sepsis and in auto-inflammatory disorders for which he was awarded the Young Investigator Research Award by the European Society of Clinical Microbiology and Infectious Diseases. He has 538 publications in international peer-reviewed journals with more than 35,000 citations. He has contributed in the development of clarithromycin for immunomodulatory treatment of septic shock, the recognition of hidradenitis suppurativa (HS) as an auto-inflammatory disorder, and in the licensing of adalimumab for treatment of (HS). He is the current chairman of the European Sepsis Alliance. His main achievement is the approval of anakinra for COVID-19 pneumonia in adults by the European Medicines Agency and the Food and Drug Administration through the phase 2 and 3 trials SAVE and SAVE-MORE that he designed and conducted.
Patrick Pestalozzi, MBA
Chief Executive Officer
Abionic
Patrick Pestalozzi is a former management consultant and Silicon Valley executive who is actively involved in the creation, financing, and development of multiple deep-tech startups. As a mentor, adviser, and coach to early-stage and mature organizations, he helps founders in the areas of growth strategies, product management, organizational design, international development, and sales performance. As a dual Swiss/US citizen who speaks English, French, and German, he maintains global insight and cultural sensitivity from extensive travel/work in 60+ countries.
-
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 12:00 - 12:15 pm ET
-
Includes a Live Web Event on 09/25/2024 at 9:15 AM (PDT)
Part of Sepsis Alliance Summit 2024
Description:
Date/Time: September 25, 2024 | 12:15 - 12:45 pm ET
This session delves into the critical issue of racial and ethnic disparities in sepsis care and outcomes. Attendees will gain insights into sepsis-related definitions of equity and racism and examine the extent of these disparities within healthcare systems. The presentation will also explore various proposed mechanisms contributing to these disparities, assessing their validity and impact. How systemic factors influence sepsis outcomes among different racial and ethnic groups and the importance of addressing these inequities in clinical practice will also be highlighted.
Learning Objectives
At the end of this session, the learner should be able to:
- Restate sepsis-relevant definitions of equity and racism;
- Describe known racial and ethnic disparities relevant to sepsis care and outcomes;
- Evaluate the strength of proposed mechanisms for sepsis disparities.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Christopher F. Chesley, MD, MSCE
Assistant Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Christopher F. Chesley, MD, MSCE. is an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is an adult pulmonologist, intensivist, and health equity researcher whose research work evaluates structural mechanisms for critical care disparities and develops health system initiatives to mitigate them.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.